SWOG clinical trial number
S9702

Detection of Malignant Cells in the Marrow and Peripheral Blood Progenitor Cell Products of Breast Cancer Patients Enrolled on Intergroup Randomized Study S9623

Closed
Phase
Accrual
4%
Abbreviated Title
Detection of malignant cells in marrow and PBPC products
Activated
10/01/1997
Closed
07/15/1999
Participants
NCORP, Members, Medical Oncologists, Pathologists, ECOG, NCCTG, CALGB

Research committees

Breast Cancer

Eligibility Criteria Expand/Collapse

Patients on S9623

Other Clinical Trials

SWOG Clinical Trial Number
CTSU-A012301

LoTam: A Randomized, Phase III Clinical Trial of Low-Dose Tamoxifen for Selected Patients with Molecular Low-Risk Early-Stage Breast Cancer
Research Committee(s)
Breast Cancer
Activated
02/05/2025
Open
Phase
SWOG Clinical Trial Number
S2206

A Randomized trial of neoadjuvant durvalumab plus chemotherapy versus chemotherapy alone for Adults with MammaPrint Ultrahigh (MP2) hormone receptor (HR) positive /Human Epidermal Growth Factor receptor (HER2) negative stage II-III breast cancer
Research Committee(s)
Breast Cancer
Symptom Control and Quality of Life
Activated
10/30/2023
Accrual
21%
Open
Phase
SWOG Clinical Trial Number
S2212

TIL Adapted Neo adjuvant Chemotherapy Optimization in Triple negative breast cancer (SCARLET)
Research Committee(s)
Breast Cancer
Activated
07/21/2023
Accrual
31%
Open
Phase